Pulmonary Embolism: Survival Rates, Risks, and Treatment Breakthroughs

A pulmonary embolism occurs when a blood clot blocks the pulmonary artery. This condition can be life-threatening, but many patients recover with proper care. Doctors use risk assessments to predict outcomes and guide treatment decisions. The condition is treated most commonly with anticoagulant drugs, often called blood thinners. Other options include oxygen ventilation, thrombolysis, or surgical procedures like embolectomy and thrombectomy. In severe cases, vena cava filters may be inserted to prevent further clots.

The Pulmonary Embolism Severity Index (PESI) and its simplified version (sPESI) help doctors assess risk. PESI categorises patients with 30-day mortality rates ranging from 1% to 24.5%. The sPESI, for example, shows a 1% risk for patients scoring 0 points and 10.9% for those with 1 point.

Right ventricular heart failure raises the risk of death within 24 hours by two to three times. While the condition is serious, early treatment allows many to return to normal activities in weeks. However, studies suggest that 1 in 5 diagnosed individuals may die within a year.

In Germany, around one in every 1,000 people experiences a symptomatic venous thromboembolism annually. The risk grows significantly with age, though recent trends in frequency remain unclear. Survival rates for pulmonary embolism vary, but prompt medical intervention improves outcomes. Doctors rely on risk scores and tailored treatments to reduce complications. Recovery often depends on early diagnosis and appropriate care.